Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Klerfalk Pharma AB
AB
Active
Org 5568608086
Västra Järnvägsgatan 9 F, 753 33
Uppsala
Other human health activities n.e.c.
·
NACE 8699
Est. 2011 · 14 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Other human health activities n.e.c.
/
Klerfalk Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 1M (-50% vs 2021)
1M
-50%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 0M (-100% vs 2021)
0M
-100%
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
864
778
1 069
1 139
1 639
Staff expenses
−820
−816
−803
−757
—
EBITDA
−65
−143
74
172
606
Depreciation & amort.
−28
−28
—
—
−0
EBIT
−93
−171
74
172
606
Net financials
−159
−38
97
−515
3 096
Profit before tax
−197
−75
232
−403
6 654
Tax
—
—
—
−38
−101
Net profit
−197
−75
232
−440
6 553
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
10 626
11 348
11 706
11 636
12 106
Equity
10 067
10 764
10 839
10 607
11 048
Long-term debt
—
—
—
—
0
Short-term debt
249
219
368
469
559
Total debt
249
219
368
469
559
Financial ratios
5-year trend
EBITDA margin
-7.6%
This company
15.8%
Market median
This company
Market median
148% below market
2021
2025
Equity ratio
94.7%
This company
38.2%
Market median
This company
Market median
148% above market
2021
2025
Return on equity
-2.0%
This company
18.4%
Market median
This company
Market median
111% below market
2021
2025
Net profit margin
-22.8%
This company
8.1%
Market median
This company
Market median
381% below market
2021
2025
Asset turnover
0.08×
This company
1.12×
Market median
This company
Market median
93% below market
2021
2025
Debt / equity
0.06×
This company
0.62×
Market median
This company
Market median
90% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Klerfalk Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
